Curenta
Reimagining the Long-Term Pharmacy
Overview
Raised: $103,665
Rolling Commitments ($USD)
04/30/2022
$1,165
91
2020
Healthcare & Pharmaceuticals
Medtech
B2B
Medium
Low
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$17,521 |
$0 |
COGS |
$13,455 |
$0 |
Tax |
$800 |
$800 |
| ||
| ||
Net Income |
$-239,201 |
$-800 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$33,691 |
$0 |
Accounts Receivable |
$8,030 |
$0 |
Total Assets |
$90,912 |
$0 |
Short-Term Debt |
$77,554 |
$0 |
Long-Term Debt |
$2,400 |
$0 |
Total Liabilities |
$79,954 |
$0 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual